House Status:
Senate Status:
Senate Status:
Minutes for SB377 - Committee on Public Health and Welfare
Short Title
Allowing pharmacists to administer drugs by injection pursuant to a prescription order.
Minutes Content for Tue, Feb 13, 2018
Chairperson Schmidt opened the hearing on SB377. Scott Abbott, Staff Revisor, gave an overview of the bill.
Julie Hein testified as a proponent to SB377. She stated that a need exists for increased access to medication administration services for many types of medication, such as osteoporosis, specialty medications, etc. Also, due to dexterity deficiencies, fear of needles, or other challenges, there is a need for a highly accessible health care provider to provide medication administration services for the patient. The passage of SB377 would allow those needs to be met. (Attachment 7)
Terica Gatewood spoke in support of SB377 stating that the passage of SB377 would allow pharmacists to complement the efforts of healthcare providers to help improve access to medications needed by patients. Allowing pharmacists to administer long-acting injectible drugs reduces the number of times a patient needs to remember to take their medications. (Attachment 8)
Dean Benton gave proponent testimony stating that SB377 will allow for safer and improved administration options for patients of injectible drugs administered in local communities by pharmacists. (Attachment 9)
Alexandra Blasi testified in support of SB377. She stated that the Kansas Board of Pharmacy is ready and willing to take on any oversight, including drafting and adopting any regulations. (Attachment 10)
Proponent written only testimony was submitted by Lis Houcher, National Association of Chain Drug Stores. (Attachment 11)
Representative Eplee testified in opposition of SB377 stating the reasons of practice overreach, fragmentation of care, undermining the evolving model of "Patient Centered Medical Home", lack of adequate training and no demonstrable need. (Attachment 12)
Rachelle Colombo presented opposition testimony to SB377 stating that providers ought to first discuss clinical aspects and implications and ensure standard of care is protected before passage of SB377. (Attachment 13)
Questions were taken from committee members.
Chairperson Schmidt closed the hearing on SB377.
